Clinical Trial

A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

Name: A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis — clinical trial record (NCT07660848)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to investigate the efficacy and safety of HRS-4729 injection and HRS9531 injection in adult participants with metabolic dysfunction-associated steatohepatitis after 52 weeks of treatment.

Trial Details

NCT Number	NCT07660848
Lead Sponsor	Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions	Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Enrollment	160 participants
Start Date	2026-07
Primary Completion	2028-03 (estimated)
Study Completion	2028-07 (estimated)
Updated on ClinicalTrials.gov	2026-06-22